Crowdonomics
WatchlistPortfolio
Master Foods Lab

Reg CF · Common Stock · Apr 2022

WithdrawnReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$12.9K / $1.1M max
1% of ceiling · target hit day 10
Investors
26
$494.4 avg
Post-money valuation
$10M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$14K$7K$0
28140
Apr 3, 2022 · openedJul 22, 2022 · last reading
Target ($10K) hit — Apr 13, 2022, day 10Deadline Jul 1, 2022

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2020–FY2021 · hover for source
$0
FY2020
$709K
−$421K
FY2021
RevenueNet income
Metric
FY2020 reviewed
FY2021 reviewed
Income statement
Revenue
$0
$709,021
Cost of goods sold
$0
$771,240
Gross margin
—
-9%
Net income
$0
-$421,365
Taxes paid
$0
$0
Balance sheet
Cash
$0
$2,631
Accounts receivable
$0
$0
Total assets
$0
$316,022
Short-term debt
$0
$0
Long-term debt
$0
$32,400
Total liabilities
$0
$32,400
Other
Headcount
—
6

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$10M
Post-money$10M
Price / share$10.00
Shares offered1,000

Perks

Invest within the first 7 days and receive an additional 15% bonus shares · until Apr 9, 202215% bonus

Offering details

Target$10,000
Max$1,070,000
Min investment$150
OpenedApr 3, 2022
DeadlineJul 1, 2022
ClosedJul 22, 2022
Days active110

Links & provenance

Campaign pagePitch videoSEC filingStartEngine listing
Source: Manual
0001665160-22-000604

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.